CYP1B1 and endothelial dysfunction: Hence, deregulation of eNOS signaling and endothelial dysfunction in hypertensive disorders, associated with elevated 20-HETE levels, could be reduced via potent inhibition of CYP1B1 by TMS [5,6,7,8].